Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice

Accumulating evidence indicates an interaction between inflammation and depression since increased levels of pro-inflammatory cytokines are associated with depression-related symptoms. Melatonin is a hormone synthesized and secreted by the pineal gland with antioxidant, anti-inflammatory and antidep...

Full description

Saved in:
Bibliographic Details
Published inPhysiology & behavior Vol. 188; pp. 270 - 275
Main Authors Taniguti, E.H., Ferreira, Y.S., Stupp, I.J.V., Fraga-Junior, E.B., Mendonça, C.B., Rossi, F.L., Ynoue, H.N., Doneda, D.L., Lopes, L., Lima, E., Buss, Z.S., Vandresen-Filho, S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Accumulating evidence indicates an interaction between inflammation and depression since increased levels of pro-inflammatory cytokines are associated with depression-related symptoms. Melatonin is a hormone synthesized and secreted by the pineal gland with antioxidant, anti-inflammatory and antidepressant-like effects. In this way, it would be interesting to evaluate the putative antidepressant-like effect of melatonin treatment in an acute inflammation mice model of depression. The present study aimed to investigate the effect of melatonin treatment on lipopolysaccharide (LPS) induced depressive-like behavior, neuroinflammation, oxidative stress and alteration on brain-derived neurotrophic fator (BDNF) levels. Mice were treated with melatonin (10 mg/kg, i.p.) 30 min before LPS (0.5 mg/kg, i.p.) injection. Twenty-four hours after LPS infusion, mice were submitted to the behavioral tests and, thereafter, biochemical determinations were performed. Melatonin treatment prevented LPS-induced depressive-like behavior in the forced swim and tail suspension tests with no alterations in locomotor activity evaluated in the open field test. Melatonin attenuated LPS-induced increase in tumor necrosis factor-α (TNF-α) and reduction of BDNF levels in the hippocampus. Treatment with melatonin also prevented LPS-induced increase in lipid peroxidation and the reduction of glutathione levels in the hippocampus. In conclusion, the present study suggests that melatonin treatment exerted neuroprotective effects against LPS-induced depressive-like behavior which may be related to reduction of TNF-α release, oxidative stress and modulation of BDNF expression. •Melatonin prevents lipopolysaccharide-induced depressive-like behavior.•Melatonin attenuates lipopolysaccharide-induced hippocampal expression of TNF-α.•Melatonin prevents increased oxidative stress induced by lipopolysaccharide.•Melatonin abolishes the reduction of BDNF levels induced by lipopolysaccharide.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0031-9384
1873-507X
DOI:10.1016/j.physbeh.2018.02.034